Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$189.33
+0.4%
$180.58
$141.74
$263.24
$13.66B1.64911,921 shs562,316 shs
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$9.48
+1.0%
$9.85
$9.17
$14.14
N/A0.36200,957 shs178,401 shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$78.34
+0.2%
$75.62
$58.93
$95.25
$45.88B1.125.23 million shs3.10 million shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.67
+1.5%
$28.67
$23.69
$31.72
$13.24B0.68816,835 shs626,237 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$91.23
-0.3%
$94.65
$89.22
$116.71
$18.10B0.721.81 million shs1.25 million shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
0.00%+3.70%+4.30%+18.67%-21.92%
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
0.00%+0.11%-1.47%-10.57%-22.27%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.00%+5.81%-0.02%+7.59%-15.48%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.00%+5.02%+4.44%+6.55%+22.05%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.00%+0.27%-0.72%-19.30%-15.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.8387 of 5 stars
4.34.00.03.83.61.71.3
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/AN/AN/AN/AN/AN/AN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
4.3127 of 5 stars
2.23.00.04.02.52.52.5
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3.5713 of 5 stars
1.05.02.50.02.70.04.4
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.8491 of 5 stars
3.13.02.53.72.52.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.67
Moderate Buy$241.2527.42% Upside
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
2.40
HoldN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.40
Hold$80.202.37% Upside
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$28.00-8.71% Downside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$111.5322.25% Upside

Current Analyst Ratings Breakdown

Latest ALGN, EW, ZBH, CLPBY, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/2/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/22/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$84.00 ➝ $95.00
5/13/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$80.00 ➝ $83.00
5/12/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$115.00 ➝ $101.00
5/9/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
5/7/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/7/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$140.00 ➝ $125.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$101.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$138.00 ➝ $115.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$120.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$119.00 ➝ $104.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B3.43$9.03 per share20.97$51.60 per share3.67
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$3.93BN/AN/AN/AN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$5.44B8.45$2.74 per share28.64$17.06 per share4.59
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.31$3.20 per share9.57$12.04 per share2.55
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.35$13.16 per share6.93$62.67 per share1.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.4934.4921.152.0010.29%13.52%8.36%7/23/2025 (Estimated)
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$734.56M$0.3031.6023.703.5716.38%27.29%9.40%8/19/2025 (Estimated)
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$4.17B$7.0011.1928.493.9475.48%16.62%12.64%7/23/2025 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1614.2015.340.93N/AN/AN/A8/5/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5220.1810.292.1111.86%12.73%7.34%8/6/2025 (Estimated)

Latest ALGN, EW, ZBH, CLPBY, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.57N/AN/AN/AN/AN/A
7/23/2025Q2 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.62N/AN/AN/A$1.49 billionN/A
5/6/2025Q2 2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.0874$0.06-$0.0274$0.06$7.02 billion$1.05 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
4/30/2025Q1 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.00$2.13+$0.13$1.27$977.90 million$979.26 million
4/23/2025Q1 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.60$0.64+$0.04$0.61$1.40 billion$1.41 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.080.84%N/A26.67%N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.90%N/A41.20%N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.05%N/A21.24%N/A

Latest ALGN, EW, ZBH, CLPBY, and SNN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.03%6/26/20256/26/20257/31/2025
5/16/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.03892.02%5/16/20255/19/20255/22/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.21
1.08
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
0.98
0.95
0.61
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.45
3.66
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.89
1.33
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.53
2.44
1.46

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,94572.49 million72.01 millionOptionable
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
16,875N/AN/ANot Optionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
15,800586.60 million584.61 millionOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.97 million433.59 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000197.85 million196.46 millionOptionable

Recent News About These Companies

ZBH - Zimmer Biomet Holdings Inc Executives | Morningstar
ZBH - Zimmer Biomet Holdings Inc Executives | Morningstar
Q2 EPS Estimates for Zimmer Biomet Lowered by Zacks Research
ZBH - Zimmer Biomet Holdings Inc Dividends | Morningstar
ZBH Zimmer Biomet Holdings, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$189.33 +0.81 (+0.43%)
As of 04:00 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Coloplast A/S stock logo

Coloplast A/S OTCMKTS:CLPBY

$9.48 +0.09 (+0.96%)
As of 03:59 PM Eastern

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$78.34 +0.13 (+0.17%)
As of 03:58 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$30.67 +0.45 (+1.49%)
As of 03:58 PM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$91.23 -0.23 (-0.25%)
As of 03:58 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.